Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ANVS
ANVS logo

ANVS Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Annovis Bio Inc (ANVS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.750
1 Day change
0.57%
52 Week Range
5.500
Analysis Updated At
2026/06/18
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Annovis Bio Inc (ANVS) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are bearish, options data reflects negative sentiment, and there are no significant positive catalysts or financial data to support a buy decision. Holding off on this investment would be prudent.

Technical Analysis

The MACD histogram is negative and contracting (-0.00687), RSI is neutral at 37.96, and moving averages are bearish (SMA_200 > SMA_20 > SMA_5). Support is at 1.715, resistance at 1.914. Stock trend analysis predicts a -12.34% decline in the next month.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

High put-call ratio in volume indicates bearish sentiment, with call open interest at 29,734 and put open interest at 2,348.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
3

Positive Catalysts

  • Insiders are buying, with a 673.49% increase in buying activity over the last month.

Neutral/Negative Catalysts

  • No recent news, no significant hedge fund activity, bearish technical indicators, and a high probability of price decline in the short term.

Financial Performance

No financial data available for analysis.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

Wall Street analysts forecast ANVS stock price to rise
2 Analyst Rating
Wall Street analysts forecast ANVS stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.740
sliders
Low
8
Averages
12.5
High
17
Current: 1.740
sliders
Low
8
Averages
12.5
High
17
H.C. Wainwright
H.C. Wainwright
Buy
downgrade
$12 -> $10
AI Analysis
2025-09-03
Reason
H.C. Wainwright
H.C. Wainwright
Price Target
$12 -> $10
AI Analysis
2025-09-03
downgrade
Buy
Reason
H.C. Wainwright lowered the firm's price target on Annovis Bio to $10 from $12 and keeps a Buy rating on the shares. The firm says the company's buntanetap Alzheimer's disease pivotal trial remains in progress. It cites a lengthier time to potential approval for the target cut.

People Also Watch